$NTLA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intellia Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Intellia Therapeutics, Inc.. Get notifications about new insider transactions in Intellia Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 25 2021 | NTLA | Intellia Therapeut ... | Crowley John F | Director | Option Exercise | A | 83.59 | 3,382 | 282,701 | 3,382 | |
Jun 25 2021 | NTLA | Intellia Therapeut ... | Crowley John F | Director | Grant | A | 0.00 | 2,094 | 0 | 2,094 | 0 to 2.1 K |
Jun 25 2021 | NTLA | Intellia Therapeut ... | Crowley John F | Director | Option Exercise | A | 83.59 | 3,382 | 282,701 | 3,382 | |
Jun 25 2021 | NTLA | Intellia Therapeut ... | Crowley John F | Director | Grant | A | 0.00 | 2,094 | 0 | 2,094 | 0 to 2.1 K |
Apr 30 2021 | NTLA | Intellia Therapeut ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 85.43 | 4,513 | 385,546 | 765,101 | 769.6 K to 765.1 K (-0.59 %) |
Apr 28 2021 | NTLA | Intellia Therapeut ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 86.12 | 29,740 | 2,561,209 | 769,614 | 799.4 K to 769.6 K (-3.72 %) |
Apr 28 2021 | NTLA | Intellia Therapeut ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 85.40 | 102,186 | 8,726,684 | 799,354 | 901.5 K to 799.4 K (-11.33 %) |
Apr 28 2021 | NTLA | Intellia Therapeut ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 87.08 | 61,680 | 5,371,094 | 901,540 | 963.2 K to 901.5 K (-6.40 %) |
Apr 28 2021 | NTLA | Intellia Therapeut ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 86.41 | 68,836 | 5,948,119 | 963,220 | 1 M to 963.2 K (-6.67 %) |
Apr 28 2021 | NTLA | Intellia Therapeut ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 85.39 | 79,714 | 6,806,778 | 1,032,056 | 1.1 M to 1 M (-7.17 %) |
Apr 28 2021 | NTLA | Intellia Therapeut ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 84.93 | 806 | 68,454 | 1,111,770 | 1.1 M to 1.1 M (-0.07 %) |
Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 13.88 | 15,937 | 221,206 | 15,937 | |
Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 6.83 | 10,000 | 68,300 | 10,000 | |
Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 13.88 | 15,937 | 221,206 | 719,305 | 703.4 K to 719.3 K (+2.27 %) |
Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 6.83 | 10,000 | 68,300 | 703,368 | 693.4 K to 703.4 K (+1.44 %) |
Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 13.88 | 15,937 | 221,206 | 15,937 | |
Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 6.83 | 10,000 | 68,300 | 10,000 | |
Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 13.88 | 15,937 | 221,206 | 719,305 | 703.4 K to 719.3 K (+2.27 %) |
Apr 15 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 6.83 | 10,000 | 68,300 | 703,368 | 693.4 K to 703.4 K (+1.44 %) |
Apr 13 2021 | NTLA | Intellia Therapeut ... | Keresty Georgia | Director | Option Exercise | A | 70.64 | 7,755 | 547,813 | 7,755 | |
Apr 13 2021 | NTLA | Intellia Therapeut ... | Keresty Georgia | Director | Grant | A | 0.00 | 4,955 | 0 | 4,955 | 0 to 5 K |
Apr 07 2021 | NTLA | Intellia Therapeut ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 84.98 | 800 | 67,984 | 1,112,576 | 1.1 M to 1.1 M (-0.07 %) |
Apr 06 2021 | NTLA | Intellia Therapeut ... | DORSA CAROLINE | Director | Option Exercise | M | 6.40 | 7,500 | 48,000 | 9,088 | |
Apr 06 2021 | NTLA | Intellia Therapeut ... | DORSA CAROLINE | Director | Sell | S | 82.99 | 800 | 66,392 | 5,410 | 6.2 K to 5.4 K (-12.88 %) |
Apr 06 2021 | NTLA | Intellia Therapeut ... | DORSA CAROLINE | Director | Sell | S | 82.35 | 4,686 | 385,892 | 6,210 | 10.9 K to 6.2 K (-43.01 %) |
Apr 06 2021 | NTLA | Intellia Therapeut ... | DORSA CAROLINE | Director | Sell | S | 81.49 | 2,014 | 164,121 | 10,896 | 12.9 K to 10.9 K (-15.60 %) |
Apr 06 2021 | NTLA | Intellia Therapeut ... | DORSA CAROLINE | Director | Buy | M | 6.40 | 7,500 | 48,000 | 12,910 | 5.4 K to 12.9 K (+138.63 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 13.40 | 26,041 | 348,949 | 273,959 | |
Apr 02 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 14.58 | 45,000 | 656,100 | 155,000 | |
Apr 02 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 83.00 | 13,895 | 1,153,285 | 693,368 | 707.3 K to 693.4 K (-1.96 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 13.40 | 26,041 | 348,949 | 707,263 | 681.2 K to 707.3 K (+3.82 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 84.00 | 24,314 | 2,042,376 | 681,222 | 705.5 K to 681.2 K (-3.45 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 14.58 | 45,000 | 656,100 | 705,536 | 660.5 K to 705.5 K (+6.81 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Option Exercise | M | 6.83 | 33,001 | 225,397 | 6,116 | |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Option Exercise | M | 14.58 | 10,000 | 145,800 | 51,000 | |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Option Exercise | M | 18.30 | 21,000 | 384,300 | 29,090 | |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Option Exercise | M | 13.88 | 33,000 | 458,040 | 39,000 | |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 85.76 | 124 | 10,634 | 162,388 | 162.5 K to 162.4 K (-0.08 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 84.73 | 1,213 | 102,777 | 162,512 | 163.7 K to 162.5 K (-0.74 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 83.85 | 2,258 | 189,333 | 163,725 | 166 K to 163.7 K (-1.36 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 82.77 | 3,361 | 278,190 | 165,983 | 169.3 K to 166 K (-1.98 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 81.87 | 6,768 | 554,096 | 169,344 | 176.1 K to 169.3 K (-3.84 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 80.85 | 1,965 | 158,870 | 176,112 | 178.1 K to 176.1 K (-1.10 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Buy | M | 6.83 | 33,001 | 225,397 | 178,077 | 145.1 K to 178.1 K (+22.75 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 85.14 | 123 | 10,472 | 145,076 | 145.2 K to 145.1 K (-0.08 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 83.98 | 1,049 | 88,095 | 145,199 | 146.2 K to 145.2 K (-0.72 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 82.87 | 951 | 78,809 | 146,248 | 147.2 K to 146.2 K (-0.65 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 81.95 | 2,644 | 216,676 | 147,199 | 149.8 K to 147.2 K (-1.76 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 80.73 | 700 | 56,511 | 149,843 | 150.5 K to 149.8 K (-0.46 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Buy | M | 14.58 | 10,000 | 145,800 | 150,543 | 140.5 K to 150.5 K (+7.12 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 84.87 | 963 | 81,730 | 140,543 | 141.5 K to 140.5 K (-0.68 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 83.72 | 1,724 | 144,333 | 141,506 | 143.2 K to 141.5 K (-1.20 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 82.63 | 2,728 | 225,415 | 143,230 | 146 K to 143.2 K (-1.87 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 81.83 | 4,818 | 394,257 | 145,958 | 150.8 K to 146 K (-3.20 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 80.82 | 1,256 | 101,510 | 150,776 | 152 K to 150.8 K (-0.83 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Buy | M | 18.30 | 21,000 | 384,300 | 152,032 | 131 K to 152 K (+16.03 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 84.94 | 1,067 | 90,631 | 131,032 | 132.1 K to 131 K (-0.81 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 83.91 | 3,234 | 271,365 | 132,099 | 135.3 K to 132.1 K (-2.39 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 82.76 | 3,233 | 267,563 | 135,333 | 138.6 K to 135.3 K (-2.33 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 81.89 | 8,266 | 676,903 | 138,566 | 146.8 K to 138.6 K (-5.63 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 80.79 | 2,010 | 162,388 | 146,832 | 148.8 K to 146.8 K (-1.35 %) |
Apr 02 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Buy | M | 13.88 | 33,000 | 458,040 | 148,842 | 115.8 K to 148.8 K (+28.49 %) |
Mar 05 2021 | NTLA | Intellia Therapeut ... | Sepp-Lorenzino Laura | EVP, Chief Scientif ... | Option Exercise | A | 0.00 | 14,000 | 0 | 14,000 | |
Mar 05 2021 | NTLA | Intellia Therapeut ... | Sepp-Lorenzino Laura | EVP, Chief Scientif ... | Option Exercise | A | 57.71 | 84,000 | 4,847,640 | 84,000 | |
Mar 05 2021 | NTLA | Intellia Therapeut ... | SCHIERMEIER ANDREW | EVP, Chief Operatin ... | Option Exercise | A | 0.00 | 13,125 | 0 | 13,125 | |
Mar 05 2021 | NTLA | Intellia Therapeut ... | SCHIERMEIER ANDREW | EVP, Chief Operatin ... | Option Exercise | A | 57.71 | 78,750 | 4,544,663 | 78,750 | |
Mar 05 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Option Exercise | A | 0.00 | 12,250 | 0 | 12,250 | |
Mar 05 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Option Exercise | A | 57.71 | 73,500 | 4,241,685 | 73,500 | |
Mar 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | A | 0.00 | 31,394 | 0 | 31,394 | |
Mar 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | A | 57.71 | 188,363 | 10,870,429 | 188,363 | |
Mar 05 2021 | NTLA | Intellia Therapeut ... | Lebwohl David | EVP, Chief Medical ... | Option Exercise | A | 0.00 | 12,750 | 0 | 12,750 | |
Mar 05 2021 | NTLA | Intellia Therapeut ... | Lebwohl David | EVP, Chief Medical ... | Option Exercise | A | 57.71 | 76,500 | 4,414,815 | 76,500 | |
Mar 05 2021 | NTLA | Intellia Therapeut ... | Goddard Glenn | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 12,250 | 0 | 12,250 | |
Mar 05 2021 | NTLA | Intellia Therapeut ... | Goddard Glenn | EVP, Chief Financia ... | Option Exercise | A | 57.71 | 73,500 | 4,241,685 | 73,500 | |
Mar 01 2021 | NTLA | Intellia Therapeut ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 60.29 | 501,945 | 30,262,716 | 1,113,376 | 1.6 M to 1.1 M (-31.07 %) |
Feb 09 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Option Exercise | M | 18.30 | 21,000 | 384,195 | 50,090 | |
Feb 09 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 75.00 | 11,489 | 861,675 | 117,920 | 129.4 K to 117.9 K (-8.88 %) |
Feb 09 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Buy | M | 18.30 | 21,000 | 384,195 | 129,409 | 108.4 K to 129.4 K (+19.37 %) |
Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 6.83 | 56,718 | 387,384 | 68,516 | |
Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 13.40 | 40,000 | 536,000 | 285,453 | |
Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 75.00 | 28,043 | 2,103,225 | 660,536 | 688.6 K to 660.5 K (-4.07 %) |
Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 6.83 | 56,718 | 387,384 | 688,579 | 631.9 K to 688.6 K (+8.98 %) |
Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 68.78 | 881 | 60,595 | 631,861 | 632.7 K to 631.9 K (-0.14 %) |
Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 67.86 | 14,018 | 951,261 | 632,742 | 646.8 K to 632.7 K (-2.17 %) |
Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 67.18 | 8,043 | 540,329 | 646,760 | 654.8 K to 646.8 K (-1.23 %) |
Feb 09 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 13.40 | 40,000 | 536,000 | 654,803 | 614.8 K to 654.8 K (+6.51 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 13.88 | 67,060 | 930,793 | 17,940 | |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 22.78 | 50,000 | 1,139,000 | 110,000 | |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 22.78 | 60,000 | 1,366,800 | 160,000 | |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 18.30 | 30,000 | 548,850 | 27,500 | |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 13.88 | 10,000 | 138,800 | 85,000 | |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 6.83 | 100,000 | 683,000 | 125,234 | |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 73.00 | 36,858 | 2,690,634 | 614,803 | 651.7 K to 614.8 K (-5.66 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 13.88 | 67,060 | 930,793 | 651,661 | 584.6 K to 651.7 K (+11.47 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 72.00 | 30,998 | 2,231,856 | 584,601 | 615.6 K to 584.6 K (-5.04 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 22.78 | 50,000 | 1,139,000 | 615,599 | 565.6 K to 615.6 K (+8.84 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 65.04 | 5,475 | 356,094 | 565,599 | 571.1 K to 565.6 K (-0.96 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 64.10 | 16,640 | 1,066,624 | 571,074 | 587.7 K to 571.1 K (-2.83 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 63.30 | 11,100 | 702,630 | 587,714 | 598.8 K to 587.7 K (-1.85 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 22.78 | 60,000 | 1,366,800 | 598,814 | 538.8 K to 598.8 K (+11.14 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 65.03 | 3,260 | 211,998 | 538,814 | 542.1 K to 538.8 K (-0.60 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 64.09 | 9,432 | 604,497 | 542,074 | 551.5 K to 542.1 K (-1.71 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 63.29 | 6,448 | 408,094 | 551,506 | 558 K to 551.5 K (-1.16 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 18.30 | 30,000 | 549,000 | 557,954 | 528 K to 558 K (+5.68 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 65.02 | 693 | 45,059 | 527,954 | 528.6 K to 528 K (-0.13 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 64.16 | 3,497 | 224,368 | 528,647 | 532.1 K to 528.6 K (-0.66 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 63.24 | 1,709 | 108,077 | 532,144 | 533.9 K to 532.1 K (-0.32 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 13.88 | 10,000 | 138,800 | 533,853 | 523.9 K to 533.9 K (+1.91 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 65.00 | 8,827 | 573,755 | 523,853 | 532.7 K to 523.9 K (-1.66 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 64.13 | 26,058 | 1,671,100 | 532,680 | 558.7 K to 532.7 K (-4.66 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 63.32 | 16,750 | 1,060,610 | 558,738 | 575.5 K to 558.7 K (-2.91 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 6.83 | 100,000 | 683,000 | 575,488 | 475.5 K to 575.5 K (+21.03 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Option Exercise | M | 14.58 | 10,000 | 145,800 | 61,000 | |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Option Exercise | M | 13.88 | 33,000 | 458,040 | 72,000 | |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Option Exercise | M | 6.83 | 66,000 | 450,780 | 39,117 | |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 65.07 | 755 | 49,128 | 108,409 | 109.2 K to 108.4 K (-0.69 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 64.18 | 2,386 | 153,133 | 109,164 | 111.6 K to 109.2 K (-2.14 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 63.44 | 2,326 | 147,561 | 111,550 | 113.9 K to 111.6 K (-2.04 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Buy | M | 14.58 | 10,000 | 145,800 | 113,876 | 103.9 K to 113.9 K (+9.63 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 65.05 | 2,827 | 183,896 | 103,876 | 106.7 K to 103.9 K (-2.65 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 64.16 | 8,366 | 536,763 | 106,703 | 115.1 K to 106.7 K (-7.27 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 63.34 | 6,617 | 419,121 | 115,069 | 121.7 K to 115.1 K (-5.44 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Buy | M | 13.88 | 33,000 | 458,040 | 121,686 | 88.7 K to 121.7 K (+37.21 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 65.01 | 5,312 | 345,333 | 88,686 | 94 K to 88.7 K (-5.65 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 64.11 | 15,594 | 999,731 | 93,998 | 109.6 K to 94 K (-14.23 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 63.31 | 10,476 | 663,236 | 109,592 | 120.1 K to 109.6 K (-8.73 %) |
Feb 03 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Buy | M | 6.83 | 66,000 | 450,780 | 120,068 | 54.1 K to 120.1 K (+122.07 %) |
Jan 22 2021 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Option Exercise | M | 13.78 | 20,000 | 275,600 | 18,000 | |
Jan 22 2021 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Buy | M | 13.78 | 20,000 | 275,600 | 30,000 | 10 K to 30 K (+200.00 %) |
Jan 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | M | 0.00 | 14,375 | 0 | 0 | |
Jan 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | A | 0.00 | 14,375 | 0 | 14,375 | |
Jan 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Option Exercise | A | 23.46 | 28,750 | 674,475 | 28,750 | |
Jan 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Sell | S | 55.86 | 6,239 | 348,511 | 475,488 | 481.7 K to 475.5 K (-1.30 %) |
Jan 05 2021 | NTLA | Intellia Therapeut ... | LEONARD JOHN M | President and CEO | Buy | M | 0.00 | 14,375 | 0 | 481,727 | 467.4 K to 481.7 K (+3.08 %) |
Jan 05 2021 | NTLA | Intellia Therapeut ... | SCHIERMEIER ANDREW | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 4,792 | 0 | 0 | |
Jan 05 2021 | NTLA | Intellia Therapeut ... | SCHIERMEIER ANDREW | EVP, Chief Operatin ... | Option Exercise | A | 0.00 | 4,792 | 0 | 4,792 | |
Jan 05 2021 | NTLA | Intellia Therapeut ... | SCHIERMEIER ANDREW | EVP, Chief Operatin ... | Option Exercise | A | 20.56 | 9,583 | 197,026 | 9,583 | |
Jan 05 2021 | NTLA | Intellia Therapeut ... | SCHIERMEIER ANDREW | EVP, Chief Operatin ... | Sell | S | 55.86 | 1,377 | 76,919 | 16,656 | 18 K to 16.7 K (-7.64 %) |
Jan 05 2021 | NTLA | Intellia Therapeut ... | SCHIERMEIER ANDREW | EVP, Chief Operatin ... | Buy | M | 0.00 | 4,792 | 0 | 18,033 | 13.2 K to 18 K (+36.19 %) |
Jan 05 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Option Exercise | M | 0.00 | 4,792 | 0 | 0 | |
Jan 05 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Option Exercise | A | 0.00 | 4,792 | 0 | 4,792 | |
Jan 05 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Option Exercise | A | 23.46 | 9,583 | 224,817 | 9,583 | |
Jan 05 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Sell | S | 55.86 | 2,078 | 116,077 | 51,990 | 54.1 K to 52 K (-3.84 %) |
Jan 05 2021 | NTLA | Intellia Therapeut ... | Rivera Jose E | EVP, General Counse ... | Buy | M | 0.00 | 4,792 | 0 | 54,068 | 49.3 K to 54.1 K (+9.72 %) |
Jan 04 2021 | NTLA | Intellia Therapeut ... | SCHIERMEIER ANDREW | EVP, Chief Operatin ... | Option Exercise | M | 13.48 | 1,500 | 20,220 | 148,500 | |
Jan 04 2021 | NTLA | Intellia Therapeut ... | SCHIERMEIER ANDREW | EVP, Chief Operatin ... | Buy | M | 13.48 | 1,500 | 20,220 | 12,673 | 11.2 K to 12.7 K (+13.43 %) |
Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | M | 15.78 | 19,000 | 299,820 | 0 | |
Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | M | 25.98 | 19,000 | 493,620 | 0 | |
Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | M | 14.35 | 19,000 | 272,650 | 0 | |
Dec 18 2020 | NTLA | Intellia Therapeut ... | KARSEN PERRY A | Director | Option Exercise | M | 18.00 | 31,764 | 571,752 | 0 |